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Sight threating diabetic retinopathy (STDR) is a sight threatening condition 
screened for every year in all patients with diabetes in the UK. Only around 4% of 
patients with diabetes develop STDR each year, so testing all patients is very 
inefficient. Our aim is to accurately identify patients at high risk of developing 
STDR using longitudinal models and discriminant analysis. 
Recent developments have been made in discriminant analysis where longitudinal 
trends are modelled using multivariate generalized linear mixed models. We model 
longitudinal markers using mixed models and then use the parameter estimates 
from this in a discriminant analysis to predict the group membership of new 
patients. 
We extend this existing discriminant analysis methodology for longitudinal data by 
allowing covariate information to be used as discriminators, and not just to 
influence the longitudinal trends.   
We analyse data from a longitudinal study of over 12,000 patients diagnosed with 
diabetes and use our method to classify these patients into risk groups. Initial 
results demonstrate an advantage in using longitudinal information over classic 
discriminant analysis methods.  
We also explore early prediction methods to see if we can correctly identify 
patients sooner than with current methods. We expect that this methodology will 
lead to better detection of STDR, and hence improved patient care, whilst also 
significantly reducing the screening costs for the NHS. 
